Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Meso Scale Diagnostics has received 510(k) clearance from the FDA for its conventional CRP assay for IVD use in the United States.
read more
ProBioGen AG and Merus N.V. jointly announced that Merus has signed a commercial multi-product license agreement for ProBioGen’s GlymaxX® ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) enhancement technology.
read more
Wednesday, February 03, 2016
Mersana Therapeutics and Takeda Pharmaceutical Company have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada.
read more
Thursday, September 20, 2018
Merrimack Pharmaceuticals has received a $5 million milestone payment from Shire, triggered by the sale of Onivyde in the first major non-European, non-Asian country.
read more
Wednesday, April 12, 2023
Meridian Medical Technologies, a Kindeva Drug Delivery Company, a global CDMO focused on drug-device combination products, announced it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next ...
read more
INC Research Holdings and inVentiv Health announced their Boards of Directors have approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock transaction.
read more
Wednesday, January 05, 2022
Dipharma Francis, a global CDMO and a manufacturer of APIs and intermediates for generic and contract manufacturing markets, is announced that Kalexsyn, Inc., a Michigan corporation acquired in 2018, has been merged into its 100% owner, Dipharma Inc....
read more
Wednesday, January 15, 2020
Mereo BioPharma announced a global license agreement for the development and commercialization of navicixizumab.
read more
Wednesday, December 04, 2024
Merck announced that the National Medical Products Administration (NMPA) in China has approved WELIREG® (belzutifan), for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (...
read more
Thursday, September 05, 2013
Merck, known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk varicella at the company’s site in Durham, N.C., for use in Merck’s vaccines ...
read more
Wednesday, September 30, 2015
Merck expects the Latin America region to keep driving growth at its Consumer Health business, as demand for consumer goods in the region is constantly rising.
read more
Wednesday, March 20, 2019
Merck and NGM announced Merck has exercised its option to extend the research phase of the companies’ collaboration for an additional two-year period to March 2022.
read more
Thursday, December 27, 2018
Merck has announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.
read more
Tuesday, November 16, 2021
Merck announced that it will support SaudiVax Ltd., based in the Kingdom of Saudi Arabia, to design a best-in-class, multi-modality manufacturing facility to localize manufacturing of biologics and vaccines for the MENA region.
read more
Merck, a leading science and technology company, will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs' monoclonal antibody in late stage clinical development.
read more